arrow
Y

Yuichiro Tsukada

National Cancer Center Hospital East
H指数:18
被引数:1,359

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anterior tumour location as a risk factor for local recurrence after laparoscopic surgery for stage I ultra-low rectal cancers: exploratory analysis of the Ultimate trial

腹腔镜手术治疗后期超低位直肠癌中肿瘤前部位置作为局部复发风险因素的探索性分析:Ultimate试验

2026-09-300
OAAI
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma

按需GLUT3表达增强CAR T细胞在胶质母细胞瘤临床前模型中的代谢适应性和抗肿瘤效果

2026-04-010
PRE
Mitochondrial DNA abundance is a determinant of immunogenic cell death in cancer

线粒体DNA丰度是癌症中免疫原性细胞死亡的决定因素

Immunity
IF26.3
2026-01-010
OAAI
Response to Chemotherapy as a Key Factor in Time to Surgical Failure Following Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases: A Retrospective Cohort Study

化疗反应作为影响初始不可切除结直肠癌肝转移行转化肝切除术后手术失败时间的关键因素:一项回顾性队列研究

2025-11-280
PRE
Quality of life after laparoscopic surgery for very low rectal cancer: A sub-analysis of the ultimate trial

腹腔镜超低位直肠癌术后生活质量:Ultimate试验的亚组分析

2025-10-060
OAAI
A multicentre prospective study of anal function after laparoscopic ultra-low rectal cancer surgery using a mixed-effects model

一项关于腹腔镜超低位直肠癌手术后肛门功能的多中心前瞻性研究,采用混合效应模型

2025-05-250
OA
Longitudinal follow-up of sexual function after surgery for ultra-low rectal cancers located within 5 cm of the anal verge: A multicentre collaborative study

术后5 cm范围内超低位直肠癌患者性功能的纵向随访:一项多中心协作研究

2025-04-180
OAAI
Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay

基于无组织样本的表观基因组微小残留病检测用于结直肠癌复发预测

2024-08-071
OAAI
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer

术前放化疗联合nivolumab治疗微卫星稳定和微卫星不稳定高位局部晚期直肠癌的三年预后

2024-06-042
PRE